Last updated:
Author(s):
Ze-Yu Li, Chen-Jie Fei, Rui-Ying Yin, Ju-Jiao Kang, Qing Ma, Xiao-Yu He, Xin-Rui Wu, Yu-Jie Zhao, Wei Zhang, Wei-Shi Liu, Bang-Sheng Wu, Liu Yang, Ying Zhu, Jian-Feng Feng, Jin-Tai Yu, Wei Cheng
Publish date:
29 October 2024
Journal:
Molecular Psychiatry
PubMed ID:
39472661

Abstract

Previous genome-wide association studies of depression have primarily focused on common variants, limiting our comprehensive understanding of the genetic architecture. In contrast, whole-exome sequencing can capture rare coding variants, helping to explore the phenotypic consequences of altering protein-coding genes. Here, we conducted a large-scale exome-wide association study on 296,199 participants from the UK Biobank, assessing their depressive symptom scores through the Patient Health Questionnaire-4. We identified 22 genes associated with depressive symptoms, including 6 newly discovered genes (TRIM27, UBD, SVOP, ADGRB2, IRF2BPL, and ANKRD12). Both ontology enrichment analysis and plasma proteomics association analysis consistently revealed that the identified genes were associated with immune responses. Furthermore, we identified associations between these genes and brain regions related to depression, such as anterior cingulate cortex and orbitofrontal cortex. Additionally, phenome-wide association analysis demonstrated that TRIM27 and UBD were associated with neuropsychiatric, cognitive, biochemistry, and inflammatory traits. Our findings offer new insights into the potential mechanisms and genetic architecture of depressive symptoms.

Related projects

1. What is the primary change of the brain (including functional connectivity, gray matter volume and fiber integrity) for major psychiatric disorders? 2. Are…

Institution:
University of Warwick, Great Britain

All projects